Two recent studies analysing cells from patients with SoJIA give evidence that an IL-1-blockade prevents and/or reverses the differentiation of ɣ/δ T cells and regulatory T cells into a Th17 phenotype [128,129]. Here, IL1B is linked to systemic-onset juvenile idiopathic arthritis.